Luteal Phase Supplementation With Recombinant LH After GnRh Agonist Oocytes Triggering in Women at Risk of OHSS
Status:
Completed
Trial end date:
2014-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to prove that luteal phase supplementation with recombinant LH
can solve the luteal phase deficiency after Gnrh agonist oocytes triggering in women at risk
of OHSS